aTyr Pharma, Inc. (ATYR)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
ATYR price, last 12 months
Key stats
- Previous close
- $4.08
- Open
- $4.10
- Day range
- $3.69 – $4.21
- 52-week range
- $3.69 – $44.40
- Volume
- 80.6K
- Avg volume (20 days)
- 120K
- Market cap
- $15.6M
Performance
Technicals and fundamentals
About aTyr Pharma, Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $15.6M